Sirt1 ameliorates systemic sclerosis by targeting the mTOR pathway.
Zhu X, Chu H, Jiang S, Liu Q, Liu L, Xue Y, Zheng S, Wan W, Qiu J, Wang J, Zou H.
Zhu X, et al. Among authors: wan w.
J Dermatol Sci. 2017 Aug;87(2):149-158. doi: 10.1016/j.jdermsci.2017.04.013. Epub 2017 May 3.
J Dermatol Sci. 2017.
PMID: 28532580